Cancel
Guna Kannan
Senior Vice President, Protein Engineering
@
Nutcracker Therapeutics
7ldf.p5q3bb@yl763f27162.dz0
Sign up to see email
Known information
- Co-authored over 60 peer-reviewed research articles
- Earned a master's degree at the Indian Institute of Technology
- Completed a Ph.D. at the Indian Institute of Science
- Completed Post-Doctoral studies at the University of Massachusetts, Amherst
- Worked as Vice President, Head of Biotherapeutics, at Denali Therapeutics
- Was Principal Scientist and Protein Engineering and Optimization group head at Amgen Inc for nearly 10 years
- Is a listed patent co-inventor of both clinical molecules and novel platform technologies
About Nutcracker Therapeutics
Nutcracker Therapeutics is a biotechnology company focused on developing RNA-based treatments using a proprietary platform that combines advanced engineering with high-precision biosynthesis and microfluidic technology.
Report inaccurate information